The FebriDx® Bacterial/Non-Bacterial Point-of-Care Assay is a qualitative visually read rapid immunoassay for the detection of human host response protein, that uses a fingerstick blood sample to aid in the differentiation between bacterial infection and non-bacterial etiology.
Is indicated for use in patients aged 12-64 who present to urgent care or
emergency care settings for evaluation of acute respiratory infection who have had symptoms for less than 7 days and within 3 days of fever onset.
FebriDx® test results are intended to be used in conjunction with other clinical and diagnostic findings as an aid in the diagnosis of bacterial acute respiratory infection and differentiation from non-bacterial etiology. The assessment of whether a bacterial infection is present should always be based on consideration of all available information, and not based solely on the FebriDx® test results. FebriDx® test results are not intended to identify a specific pathogen or the severity of infection.
Implications of unnecessary antibiotic use
There are more than 200 million antibiotic prescriptions written each year in the outpatient setting, approximately 30-50% of which are unnecessary. Unnecessary antibiotic use leads to increased antibiotic resistance and increased costs.
FebriDx can help
FebriDx is intended to be used in urgent and emergency care settings. FebriDx offers rapid, point-of-care results that aid in diagnosing a bacterial infection which could have a direct impact on the spread of resistant bacteria.
Patient satisfaction
Patients often insist on antibiotics. Since most coughs, colds, sore throats, and runny noses are caused by non-bacterial infections, antibiotics can often be prescribed unnecessarily. FebriDx produces a tangible test result that can be shared with the patient, thereby improving patient satisfaction and confidence in their treatment recommendations.
With a 99% Negative Predictive Value, FebriDx can help rule out bacterial infection and prevent inappropriate antibiotic prescriptions.
